External Otitis: A Challenge in Management
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
The bacterial cause of external otitis was first identified during World War II, and our understanding of this condition and its management has been relatively static until recently. The use of fluoroquinolones to treat pseudomonas infections has focused attention on topical therapy for external otitis and single-drug oral therapy for skull-base osteomyelitis, which arises as a complication of external otitis. This article reviews the pathophysiology of external otitis, outlines management options with special attention to topical therapy, and presents management options for skull-base osteomyelitis.
References
1.
Rasmussen P
. Otitis externa and allergic contact dermatitis. Acta Otolaryngol. 1974; 77(5):344-7.
DOI: 10.3109/00016487409124634.
View
2.
Wright C, Meyerhoff W, Halama A
. Ototoxicity of neomycin and polymyxin B following middle ear application in the chinchilla and baboon. Am J Otol. 1987; 8(6):495-9.
View
3.
Jones R, Milazzo J, Seidlin M
. Ofloxacin otic solution for treatment of otitis externa in children and adults. Arch Otolaryngol Head Neck Surg. 1997; 123(11):1193-200.
DOI: 10.1001/archotol.1997.01900110047007.
View
4.
Hawke M, Wong J, Krajden S
. Clinical and microbiological features of otitis externa. J Otolaryngol. 1984; 13(5):289-95.
View
5.
Chai T, Chai T
. Bactericidal activity of cerumen. Antimicrob Agents Chemother. 1980; 18(4):638-41.
PMC: 284062.
DOI: 10.1128/AAC.18.4.638.
View